Holen Sie sich die Stockscreener-App
85.98
0.35%
-0.30
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$86.28
Offen:
$85.415
24-Stunden-Volumen:
12.38M
Relative Volume:
1.05
Marktkapitalisierung:
$214.76B
Einnahmen:
$63.43B
Nettoeinkommen (Verlust:
$16.42B
KGV:
13.26
EPS:
6.4861
Netto-Cashflow:
$14.72B
1W Leistung:
-1.73%
1M Leistung:
+2.44%
6M Leistung:
+0.92%
1J Leistung:
-15.97%
1-Tages-Spanne:
$84.56
$86.46
1-Wochen-Bereich:
$83.30
$88.30
52-Wochen-Spanne:
$73.31
$105.07
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Vergleichen Sie MRK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
85.98 | 215.51B | 63.43B | 16.42B | 14.72B | 6.4861 |
|
LLY
Lilly Eli Co
|
862.86 | 757.06B | 53.26B | 13.80B | -50.20M | 15.08 |
|
JNJ
Johnson Johnson
|
188.87 | 455.48B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
218.04 | 403.13B | 58.33B | 3.73B | 18.24B | 2.1013 |
|
NVS
Novartis Ag Adr
|
123.79 | 235.26B | 54.45B | 14.42B | 17.15B | 7.333 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co., Inc. $MRK Position Cut by ANTIPODES PARTNERS Ltd - MarketBeat
Atlas Private Wealth Advisors Trims Stake in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Lifeworks Advisors LLC - MarketBeat
Center for Financial Planning Inc. Sells 3,779 Shares of Merck & Co., Inc. $MRK - MarketBeat
Syverson Strege & Co Acquires Shares of 4,356 Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by AMG National Trust Bank - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by IFG Advisory LLC - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by AlphaQuest LLC - MarketBeat
Morgan Stanley Adjusts Price Target on Merck & Co. to $100 From $98 - MarketScreener
Goldman Sachs Adjusts Price Target on Merck & Co to $92 From $93 - MarketScreener
Companion Animal Health Market to Worth USD 61.74 Billion by 2034, Driven by Rising Pet Ownership and Humanization Trends - GlobeNewswire Inc.
Fisher Funds Management LTD Sells 21,137 Shares of Merck & Co., Inc. $MRK - MarketBeat
Canton Hathaway LLC Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
136,100 Shares in Merck & Co., Inc. $MRK Purchased by Lockheed Martin Investment Management Co. - MarketBeat
Earned Wealth Advisors LLC Acquires 5,613 Shares of Merck & Co., Inc. $MRK - MarketBeat
Premier Path Wealth Partners LLC Reduces Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Spire Wealth Management Sells 15,557 Shares of Merck & Co., Inc. $MRK - MarketBeat
Retirement Systems of Alabama Sells 4,775 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (NYSE:MRK) Issues Quarterly Earnings Results, Beats Expectations By $0.22 EPS - MarketBeat
Fed. Circ. Explains Rule While Upholding Merck PTAB Loss - Law360
Merck & Co Inc (MRK) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - Yahoo Finance
Merck Ready For Larger Than $15 Billion Deals, Raises Annual Profit Outlook - Benzinga
Earnings call transcript: Merck Q3 2025 beats forecasts, stock dips - Investing.com
Merck Q3 financial results top estimates, company lowers revenue guidance - Proactive financial news
Merck posts higher third-quarter sales as Keytruda offsets drop in HPV vaccine - Reuters
Merck & Co., Inc. (MRK) Stock: Q3 Profit Jumps 83% as Oncology and Animal Health Drive Growth - CoinCentral
Merck & Co., Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Merck: Wall Street Surprised By Q3 Strength, Keytruda Sales Surge (NYSE:MRK) - Seeking Alpha
Merck & Co., Inc. (NYSE:MRK) Releases FY 2025 Earnings Guidance - MarketBeat
Ledyard National Bank Has $6.72 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Adell Harriman & Carpenter Inc. Lowers Stake in Merck & Co., Inc. $MRK - MarketBeat
Strs Ohio Has $83.74 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. Updates Earnings Guidance for the Year 2025 - MarketScreener
Merck & Co. Beats Expectations in Q3 2025, Lifts Full-Year Forecast - Tokenist
Heritage Investors Management Corp Acquires 8,073 Shares of Merck & Co., Inc. $MRK - MarketBeat
Amalgamated Bank Has $38.42 Million Stake in Merck & Co., Inc. $MRK - MarketBeat
Keytruda Fuels Merck’s Growth Even As Risks Loom - Finimize
Atria Investments Inc Acquires 3,917 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck Beat Quarterly Sales Expectations Amid Pivot to New Drugs - Bloomberg.com
Noesis Capital Mangement Corp Grows Holdings in Merck & Co., Inc. $MRK - MarketBeat
Earnings Flash (MRK) Merck & Co., Inc., Rahway, N.J., USA Reports Q3 Revenue $17.28B, vs. FactSet Est of $16.97B - MarketScreener
Earnings Flash (MRK) Merck & Co., Inc., Rahway, N.J., USA Posts Q3 Adjusted EPS $2.58 per Share, vs. FactSet Est of $2.35 - MarketScreener
Merck stock dips after narrowing full-year sales outlook (MRK:NYSE) - Seeking Alpha
Merck & Co., Inc. Announces Third-Quarter 2025 Financial Results - TradingView
Merck & Co Inc. Q3 Profit Increases, Beats Estimates - Nasdaq
Keybank National Association OH Has $68.52 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc., Rahway, N.J., USA Announces Third-Quarter 2025 Financial Results - MarketScreener
Hantz Financial Services Inc. Lowers Position in Merck & Co., Inc. $MRK - MarketBeat
Eli Lilly and Merck’s blockbuster drug sales power earnings - Financial Times
Bristlecone Advisors LLC Sells 18,975 Shares of Merck & Co., Inc. $MRK - MarketBeat
World Investment Advisors Cuts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):